Hepatitis B and C viruses in the development of hepatocellular carcinoma.

[1]  C. J. Chen,et al.  Elevated serum testosterone levels and risk of hepatocellular carcinoma. , 1993, Cancer research.

[2]  C‐J. Chen,et al.  Multiple risk factors of hepatocellular carcinoma: A cohort study of 13 737 male adults in Taiwan , 1993 .

[3]  D. Trichopoulos,et al.  Association between hepatitis C virus and hepatocellular carcinoma using assays based on structural and nonstructural hepatitis C virus peptides. , 1992, Cancer research.

[4]  A. Alberti,et al.  Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV , 1992, The Lancet.

[5]  F. Chisari,et al.  Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice. , 1992, Cancer research.

[6]  B. Henderson,et al.  Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma , 1992, The Lancet.

[7]  P. Hofschneider,et al.  A chromosome 17:7 translocation is associated with a hepatitis B virus DNA integration in human hepatocellular carcinoma DNA , 1992, Hepatology.

[8]  B. Slagle,et al.  p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China. , 1992, Cancer research.

[9]  T. Tokino,et al.  Chromosomal sites for hepatitis B virus integration in human hepatocellular carcinoma , 1991, Journal of virology.

[10]  C. J. Chen,et al.  Aflatoxin B1-DNA adducts and hepatitis B virus antigens in hepatocellular carcinoma and non-tumorous liver tissue. , 1991, Carcinogenesis.

[11]  H. Hausen.  Viruses in human cancers , 1991 .

[12]  R. Weinberg,et al.  Tumor suppressor genes. , 1991, Science.

[13]  G. Nemo,et al.  HEPATITIS C VIRUS INFECTION IN POST-TRANSFUSION HEPATITIS - AN ANALYSIS WITH FIRST - AND SECOND - GENERATION ASSAYS , 1991 .

[14]  A. Lok,et al.  Overestimation of the prevalence of antibody to hepatitis C virus in retrospective studies on stored sera , 1991, Hepatology.

[15]  C. J. Chen,et al.  Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. , 1991, Cancer research.

[16]  D. Trichopoulos,et al.  Epidemiologic assessment of interactions of hepatitis‐C virus with seromarkers of hepatitis‐B and ‐D viruses, cirrhosis and tobacco smoking in hepatocellular carcinoma , 1991, International journal of cancer.

[17]  M. Feitelson,et al.  Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer. , 1991, Cancer research.

[18]  M. Houghton,et al.  Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease , 1991, Hepatology.

[19]  S. Banks,et al.  The significance of antibody to hepatitis C virus in patients with chronic hepatitis B , 1991, Hepatology.

[20]  K. Tokunaga,et al.  Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. , 1991, Cancer research.

[21]  C. Wild,et al.  Liver cancer in Thailand. II. A case‐control study of hepatocellular carcinoma , 1991, International journal of cancer.

[22]  T. Miyamura,et al.  Prevalence of antibody against the core protein of hepatitis C virus in patients with hepatocellular carcinoma , 1991, International journal of cancer.

[23]  G. Jay,et al.  HBx gene of hepatitis B virus induces liver cancer in transgenic mice , 1991, Nature.

[24]  D. Trichopoulos,et al.  Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. , 1991, JAMA.

[25]  J. Wands,et al.  Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa , 1991, Nature.

[26]  R. A. Metcalf,et al.  Mutational hot spot in the p53 gene in human hepatocellular carcinomas , 1991, Nature.

[27]  H. Varmus,et al.  Woodchuck hepatitis virus is a more efficient oncogenic agent than ground squirrel hepatitis virus in a common host , 1991, Journal of virology.

[28]  Chien-Jen Chen,et al.  Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma , 1991, Hepatology.

[29]  J. Hoofnagle,et al.  The role of chronic viral hepatitis in hepatocellular carcinoma in the United States. , 1991, The American journal of gastroenterology.

[30]  F. Chisari,et al.  Synergy between hepatitis B virus expression and chemical hepatocarcinogens in transgenic mice. , 1991, Cancer research.

[31]  H. Hsu,et al.  Hepatitis B virus integration in hepatitis B virus‐related hepatocellular carcinoma in childhood , 1991, Hepatology.

[32]  M. Houghton,et al.  A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan , 1991, Cancer.

[33]  Jane Y. Wu,et al.  The hepatitis B virus-encoded transcriptional trans-activator hbx appears to be a novel protein serine/threonine kinase , 1990, Cell.

[34]  T. Campbell,et al.  Nonassociation of aflatoxin with primary liver cancer in a cross-sectional ecological survey in the People's Republic of China. , 1990, Cancer research.

[35]  P. Roingeard,et al.  Hepatitis B virus core antigen (HBc Ag) accumulation in an HBV nonproducer clone of HepG2-transfected cells is associated with cytopathic effect. , 1990, Virology.

[36]  R. Purcell,et al.  Interrelationship of blood transfusion, non‐A, non‐B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus , 1990, Hepatology.

[37]  Chien-Jen Chen,et al.  Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. , 1990, The Journal of infectious diseases.

[38]  G. Fourel,et al.  Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours , 1990, Nature.

[39]  F. X. Bosch,et al.  Risk factors for hepatocellular carcinoma in catalonia, spain , 1990, International journal of cancer.

[40]  M. Onji,et al.  Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[41]  A. Siddiqui,et al.  Trans-activation of HLA-DR gene by hepatitis B virus X gene product. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[42]  E. Schiff,et al.  Hepatitis C–associated hepatocellular carcinoma , 1990, Hepatology.

[43]  K. Koike,et al.  Trans-activation function of a 3' truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. Cullen,et al.  Hepatic neoplasms in aflatoxin B1-treated, congenital duck hepatitis B virus-infected, and virus-free pekin ducks. , 1990, Cancer research.

[45]  P. Coursaget,et al.  Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. , 1990, Journal of the National Cancer Institute.

[46]  T. Tokino,et al.  A comparison of the molecular structure of integrated hepatitis B virus genomes in hepatocellular carcinoma cells and hepatocytes derived from the same patient , 1990, Hepatology.

[47]  A. Dejean,et al.  Hepatitis B virus as an insertional mutagene in a human hepatocellular carcinoma. , 1990, Molecular biology & medicine.

[48]  F. Chisari,et al.  Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice. , 1990, Cancer research.

[49]  M. Houghton,et al.  Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma , 1990, The Lancet.

[50]  C. Wild,et al.  Contribution of aflatoxin B1 and hepatitis B virus infection in the induction of liver tumors in ducks. , 1990, Cancer research.

[51]  M. Höhne,et al.  Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. , 1990, The EMBO journal.

[52]  P. Hofschneider,et al.  A trans-activator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[53]  D. Vergani,et al.  Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result? , 1990, The Lancet.

[54]  A. Oshima,et al.  A case‐control study of hepatocellular carcinoma in osaka, Japan , 1990, International journal of cancer.

[55]  C. Bréchot,et al.  Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma , 1990, Nature.

[56]  P. Hofschneider,et al.  The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator , 1990, Nature.

[57]  J. Esteban,et al.  High frequency of antibodies to the hepatitis C virus among patients with hepatocellular carcinoma. , 1990, Annals of internal medicine.

[58]  K. Koike,et al.  Structural rearrangement of integrated hepatitis B virus DNA as well as cellular flanking DNA is present in chronically infected hepatic tissues , 1990, Journal of virology.

[59]  C. Wild,et al.  Evaluation of methods for quantitation of aflatoxin-albumin adducts and their application to human exposure assessment. , 1990, Cancer research.

[60]  J. Rosenblatt,et al.  Detection of hepatitis C viral sequences in non-A, non-B hepatitis , 1990, The Lancet.

[61]  R. Palmiter,et al.  Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice , 1989, Cell.

[62]  M. Rapicetta,et al.  PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN HEPATOCELLULAR CARCINOMA , 1989, The Lancet.

[63]  R. Purcell,et al.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. , 1989, The New England journal of medicine.

[64]  I. Sarosi,et al.  Aflatoxin B1 formamidopyrimidine adducts in human hepatocarcinogenesis: a preliminary report. , 1989, Gastroenterology.

[65]  J. Bruix,et al.  PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN SPANISH PATIENTS WITH HEPATOCELLULAR CARCINOMA AND HEPATIC CIRRHOSIS , 1989, The Lancet.

[66]  M. Houghton,et al.  PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA , 1989, The Lancet.

[67]  M. Marconi,et al.  ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN BLOOD DONORS , 1989, The Lancet.

[68]  A. Couroucé,et al.  ANTIBODIES TO HEPATITIS C VIRUS IN FRENCH BLOOD DONORS , 1989, The Lancet.

[69]  D. Ganem,et al.  Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication , 1989, Journal of virology.

[70]  W. Stangel,et al.  ANTIBODY TO HEPATITIS C VIRUS IN GERMAN BLOOD DONORS , 1989, The Lancet.

[71]  S. De Flora,et al.  Enhanced metabolic activation of chemical hepatocarcinogens in woodchucks infected with hepatitis B virus. , 1989, Carcinogenesis.

[72]  B. Henderson,et al.  Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. , 1989, Cancer research.

[73]  M. Houghton,et al.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. , 1989, Science.

[74]  Jules L. Dienstag,et al.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis , 1989 .

[75]  K. Koike,et al.  Oncogenic potential of hepatitis B virus. , 1989, Molecular biology & medicine.

[76]  W. Robinson,et al.  Hepatitis B virus X gene can transactivate heterologous viral sequences. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[77]  K. Koike,et al.  Activated N-ras gene was found in human hepatoma tissue but only in a small fraction of the tumor cells. , 1989, Oncogene.

[78]  E. Tabor.  Hepatocellular carcinoma: Possible etiologies in patients without serologic evidence of hepatitis B virus infection , 1989, Journal of medical virology.

[79]  M. Makuuchi,et al.  Increasing incidence of hepatocellular carcinoma possibly associated with non-A, non-B hepatitis in Japan, disclosed by hepatitis B virus DNA analysis of surgically resected cases. , 1988, Cancer research.

[80]  M. Buendia,et al.  Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma , 1988, Cell.

[81]  P. Hofschneider,et al.  A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state. , 1988, Oncogene.

[82]  B. Peterlin,et al.  Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[83]  D. Ledbetter,et al.  Structural analysis of a hepatitis B virus genome integrated into chromosome 17p of a human hepatocellular carcinoma , 1988, Journal of virology.

[84]  T. Ochiya,et al.  Co-amplification of integrated hepatitis B virus DNA and transforming gene hst-1 in a hepatocellular carcinoma. , 1988, Oncogene.

[85]  C. J. Chen,et al.  A case‐control study of primary hepatocellular carcinoma in Taiwan , 1988, Cancer.

[86]  H. Popper,et al.  Non‐A, Non‐B Hepatitis‐Related Hepatocellular Carcinoma in a Chimpanzee , 1988, Journal of medical primatology.

[87]  G. Vyas,et al.  A lack of direct role of hepatitis B virus in the activation of ras and c‐myc oncogenes in human hepatocellular carcinogenesis , 1988, Hepatology.

[88]  Chien-Jen Chen,et al.  Epidemiologic Characteristics of Malignant Neoplasms in Taiwan: III. Stomach Cancer , 1988 .

[89]  H. Hsu,et al.  Status of hepatitis B virus DNA in hepatocellular carcinoma: A study based on paired tumor and nontumor liver tissues , 1988, Journal of medical virology.

[90]  T. Hunter,et al.  The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. , 1988, Science.

[91]  M. Pfahl,et al.  A new retinoic acid receptor identified from a hepatocellular carcinoma , 1988, Nature.

[92]  C. Marshall,et al.  Activation of ras oncogene in aflatoxin-induced rat liver carcinogenesis. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[93]  R. Beasley.  Hepatitis B virus. The major etiology of hepatocellular carcinoma , 1988, Cancer.

[94]  S. Tokudome,et al.  Hepatocellular carcinoma among HBsAg positive blood donors in Fukuoka, Japan. , 1988, European journal of cancer & clinical oncology.

[95]  D. Spandau,et al.  trans-activation of viral enhancers by the hepatitis B virus X protein , 1988, Journal of virology.

[96]  S. Tokudome,et al.  Hepatocellular carcinoma among female Japanese hepatitis B virus carriers. , 1987, Hepato-gastroenterology.

[97]  T. Tokino,et al.  Chromosomal translocation and inverted duplication associated with integrated hepatitis B virus in hepatocellular carcinomas , 1987, Journal of virology.

[98]  J. Twu,et al.  Transcriptional trans-activating function of hepatitis B virus , 1987, Journal of virology.

[99]  I. Fujimoto,et al.  Changing incidence of hepatocellular carcinoma in Japan. , 1987, Cancer research.

[100]  J. Butel,et al.  Integrated state of subgenomic fragments of hepatitis B virus DNA in hepatocellular carcinoma from mainland China. , 1987, Journal of the National Cancer Institute.

[101]  J. Hoofnagle,et al.  Relation of the hepatitis B virus carrier state to hepatocellular carcinoma , 1987, Hepatology.

[102]  H. Autrup,et al.  Aflatoxin exposure measured by urinary excretion of aflatoxin B1-guanine adduct and hepatitis B virus infection in areas with different liver cancer incidence in Kenya. , 1987, Cancer research.

[103]  K. Koike,et al.  Multiple integration site of hepatitis B virus DNA in hepatocellular carcinoma and chronic active hepatitis tissues from children , 1987, Journal of virology.

[104]  J. Kaldor,et al.  Aflatoxin exposure, hepatitis b virus infection and liver cancer in swaziland , 1987, International journal of cancer.

[105]  C. Croce.  Role of chromosome translocations in human neoplasia , 1987, Cell.

[106]  J. Lefkowitch,et al.  Liver cell dysplasia and hepatocellular carcinoma in non-A, non-B hepatitis. , 1987, Archives of pathology & laboratory medicine.

[107]  R. Purcell,et al.  Hepatocarcinogenicity of the woodchuck hepatitis virus. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[108]  N. Day,et al.  Hepatitis B virus, tobacco smoking and ethanol consumption in the etiology of hepatocellular carcinoma , 1987, International journal of cancer.

[109]  M. Buendia,et al.  Rearrangement and enhanced expression of c-myc in hepatocellular carcinoma of hepatitis virus infected woodchucks , 1986, Nature.

[110]  T. Shows,et al.  Hepatitis B virus integration site in hepatocellular carcinoma at chromosome 17;18 translocation. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[111]  O. Yokosuka,et al.  Integration of hepatitis b virus dna in hepatocellular carcinoma , 1986, Cancer.

[112]  P. Marion,et al.  Hepatocellular carcinoma in ground squirrels persistently infected with ground squirrel hepatitis virus. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[113]  J. Chen,et al.  Detection of hepatitis B virus DNA in hepatocellular carcinoma. , 1986, British journal of experimental pathology.

[114]  A. Morrison,et al.  A case-control study of hepatocellular carcinoma and the hepatitis B virus, cigarette smoking, and alcohol consumption. , 1986, Cancer research.

[115]  S. De Flora,et al.  Metabolic activation of hepatocarcinogens in chronic hepatitis B. , 1985, Mutation research.

[116]  T. Shows,et al.  Deletion in chromosome 11p associated with a hepatitis B integration site in hepatocellular carcinoma. , 1985, Science.

[117]  K. Koike,et al.  Hepatitis B virus integration in hepatocellular carcinoma DNA: duplication of cellular flanking sequences at the integration site. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[118]  R. Miller,et al.  Hepatitis B viral DNA in infected human liver and in hepatocellular carcinoma. , 1985, The Journal of infectious diseases.

[119]  I. Purchase,et al.  Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. , 1985, British Journal of Cancer.

[120]  R. Koretz,et al.  Non-A, non-B posttransfusion hepatitis--a decade later. , 1985, Gastroenterology.

[121]  B. Henderson,et al.  A serological case-control study of primary hepatocellular carcinoma in Guangxi, China. , 1985, Cancer research.

[122]  P. Winter,et al.  MORTALITY OF HEPATITIS B POSITIVE BLOOD DONORS IN ENGLAND AND WALES , 1985, The Lancet.

[123]  K. Geisinger,et al.  Primary hepatocellular carcinoma after chronic non-A, non-B post-transfusion hepatitis. , 1984, Annals of internal medicine.

[124]  A. Oshima,et al.  Follow‐up study of hbs ag‐positive blood donors with special reference to effect of drinking and smoking on development of liver cancer , 1984, International journal of cancer.

[125]  M. Pike,et al.  Hepatitis, alcohol consumption, cigarette smoking, and hepatocellular carcinoma in Los Angeles. , 1983, Cancer research.

[126]  J. Dienstag.  Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features , 1983 .

[127]  O. Yokosuka,et al.  Duck hepatitis B virus and liver diseases. , 1983, Gastroenterology.

[128]  B. Henderson,et al.  Hepatitis B virus and cigarette smoking: risk factors for hepatocellular carcinoma in Hong Kong. , 1982, Cancer research.

[129]  D. Shafritz,et al.  Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens. , 1981, The New England journal of medicine.

[130]  K. Nishioka,et al.  Hepatitis B virus profile of hepatocellular carcinoma in the philippines , 1981, Cancer.

[131]  C. Bréchot,et al.  State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseases. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[132]  J. Summers.  Three recently described animal virus models for human hepatitis B virus , 1981, Hepatology.

[133]  B. Werner,et al.  Association of hepatitis b virus infection with hepatocellular carcinoma in american patients , 1980, International journal of cancer.

[134]  R. Saracci,et al.  Time trends of primary liver cancer: indication of increased incidence in selected cancer registry populations. , 1980, Journal of the National Cancer Institute.

[135]  Christine Pourcel,et al.  Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma , 1980, Nature.

[136]  W. Wold,et al.  Historic milestones in cancer virology. , 1979, Seminars in oncology.

[137]  J. Summers,et al.  A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[138]  H. Gurtoo,et al.  Effect of sex difference on the in vitro and in vivo metabolism of aflatoxin B1 by the rat. , 1976, Cancer research.

[139]  W. Szmuness,et al.  A case/control study of the association between primary liver cancer and hepatitis b infection in senegal , 1975, International journal of cancer.

[140]  Wogan Gn,et al.  Dose-response characteristics of aflatoxin B1 carcinogenesis in the rat. , 1967 .

[141]  G. Leandro,et al.  The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area: a case-control study. , 1993, Cancer.

[142]  J. Groopman,et al.  Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China. , 1992, Cancer research.

[143]  J. Hendricks,et al.  Analysis of ras gene mutations in rainbow trout liver tumors initiated by aflatoxin B1 , 1991, Molecular carcinogenesis.

[144]  B. Slagle,et al.  Hepatitis B virus integration event in human chromosome 17p near the p53 gene identifies the region of the chromosome commonly deleted in virus-positive hepatocellular carcinomas. , 1991, Cancer research.

[145]  C. Bréchot,et al.  Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease. , 1991, Journal of hepatology.

[146]  G. Natoli,et al.  Antibodies to hepatitis C virus in patients with hepatocellular carcinoma. , 1991, Journal of hepatology.

[147]  J. Berman.  Cell proliferation and the aetiology of hepatocellular carcinoma. , 1988, Journal of hepatology.

[148]  P. Marion,et al.  Hepadnaviruses and retroviruses share genome homology and features of replication , 1987, Hepatology.

[149]  A. Edelman,et al.  Protein serine/threonine kinases. , 1987, Annual review of biochemistry.

[150]  K. Koike,et al.  Detection of Hepatitis B Virus DNA in Hepatocellular Carcinomas in Japan , 1984, Hepatology.

[151]  D. Shafritz.  Integration of HBV‐DNA into liver and hepatocellular carcinoma cells during persistent HBV infection , 1982, Journal of cellular biochemistry.

[152]  W. Lau,et al.  Cancer in Hong Kong: some epidemiological observations. , 1982, National Cancer Institute monograph.

[153]  D. Shafritz,et al.  Identification of integrated hepatitis B virus DNA sequences in human hepatocellular carcinomas , 1981, Hepatology.

[154]  W. Szmuness.  Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. , 1978, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale.

[155]  W. H. Butler,et al.  Acute and chronic effects of aflatoxin on the liver of domestic and laboratory animals: a review. , 1969, Cancer research.